Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Vaccine|June 10, 2022
Analytical technology development to monitor the stability of Polysaccharide-Protein conjugate vaccinesWilliam J Smith, Patrick L Ahl, Bei Wang, et al.
Vaccine|June 15, 2023
Impact of aluminum adjuvants on the stability of pneumococcal polysaccharide-protein conjugate vaccinesWilliam J Smith, Rachel Thompson, Patricia M Egan, et al.
Biotechnology Journal|September 28, 2023
Adaptation of an rVSV Ebola vaccine purification process for rapid development of a viral vaccine candidate for SARS-CoV-2Laura E Kuczynski, James R Shallow, Matthew P Watson, et al.
Biotechnology and Bioengineering|May 14, 2025
CRISPR-Editing of the Vero Cell Line Improves Processability of Live Virus Vaccines by Enabling Targeted Proteolysis of FibronectinJackson K B Cahn, Henry Ludwicki, Jillian Shingler, et al.
Vaccine|June 2, 2021
Immunogenicity of PCV24, an expanded pneumococcal conjugate vaccine, in adult monkeys and protection in miceDebra McGuinness, Robin M Kaufhold, Patrick M McHugh, et al.
ACS Omega|January 23, 2023
Understanding the Spike Protein in COVID-19 Vaccine in Recombinant Vesicular Stomatitis Virus (rVSV) Using Automated Capillary Western BlotsPaul F Gillespie, Yanjie Wang, Carl Hofmann, et al.
Biotechnology and Bioengineering|May 20, 2023
Purification processes of live virus vaccine candidates expressed in adherent Vero cell lines via multimodal chromatography in flowthrough modeSpyridon Konstantinidis, Murphy R Poplyk, Wanli Justin Ma, et al.
Vaccine|January 15, 2017
Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strainIvette Caro-Aguilar, Lani Indrawati, Robin M Kaufhold, et al.
Vaccines|January 8, 2025
Automated, Quantitative Capillary Western Blots to Analyze Host Cell Proteins in COVID-19 Vaccine Produced in Vero Cell LinePaul F Gillespie, Yanjie Wang, Kuo Yin, et al.
Biotechnology Journal|June 30, 2022
Regeneration of Capto Core 700 resin through high throughput and laboratory scale studies and impact on production of a SARS-CoV-2 vaccine candidateSpyridon Konstantinidis, Seth R Reinhart, Christine Castagna, et al.
Pageof 3